Contact

Invitation: Live Presentation with CEO Richard Paxman – Q3 2025

14 November 2025 at 09:00 CET

PAXMAN will publish its interim report for the third quarter of 2025 on 14 November at 07:00 CET. A live presentation for investors, analysts and media will be held later the same morning at 09:00 CET.
During the presentation, CEO Richard Paxman will comment on the report. The Q&A session will be moderated by Maria Karlsson Osipova, Equity Research Analyst at Carnegie. The presentation will be held in English.
To watch the presentation live, registration is required.
Register here: https://qcnl.tv/p/icmyrE28gA2KosD4huVVSA

Important information about the streaming feature
Carnegie is now using an updated version of its streaming platform. This means:

  • Immediate access
    You will gain access to the livestream as soon as you complete your registration. You will no longer receive or need a confirmation email.
  • Everything in the same window
    The video player will appear directly in the same box where you register.
  • Registering well in advance?
    If you register several days before the event, you may need to register again on the day of the presentation, as the platform does not yet consistently recognize early registrations.
Invitation: Live Presentation with CEO Richard Paxman – Q3 2025 Invitation: Live Presentation with CEO Richard Paxman – Q3 2025
What we do
Paxman are world leaders in chemotherapy side effect management on an ambitious journey to change the face of cancer through cryotherapy-based treatments. The Paxman mission is to democratise access to scalp cooling globally.
Learn more →
Financial Information
Read the latest Paxman financial reports. In these comprehensive documents, you will find a detailed overview of our financial performance, key milestones, and a strategic outlook for the future. Reports are published quarterly and annually.
Read reports  →
Investing in Paxman
Paxman has treated 100,000+ patients and installed 5,000+ systems in more than 65 countries worldwide. We are helping to manage the trauma of chemotherapy hair loss. By investing in Paxman, you're not just supporting a company; you're joining us in changing the face of cancer.
Visit the Investor Centre →
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram